Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
NCT04715048 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-12-14
Summary
The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines.
Conditions
- Glabellar Frown Lines
Interventions
- DRUG
-
PrabotulinumtoxinA
Glabellar line correction
- DRUG
-
Onabotulinum toxin A
Glabellar line correction
Sponsors & Collaborators
-
University of Southern California
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2025-05-31
- Completion
- 2025-06-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
BOTOX® in the Treatment of Upper Facial Lines in Japan
NCT01797094 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05013424 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides
NCT02261467 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
NCT01189760 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
NCT05248880 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
NCT04830345 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
NCT02261493 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
NCT01271452 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.
NCT05380154 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06583486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
NCT06174688 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines
NCT01189747 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
NCT02677805 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
NCT06218251 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
NCT06499688 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
NCT03216408 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946 ·Status: COMPLETED ·Phase: PHASE3
-
Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
NCT05766683 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
NCT02248844 ·Status: COMPLETED
-
Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles
NCT05840445 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
NCT03908008 ·Status: COMPLETED ·Phase: PHASE3